Improved outcomes from reflex comprehensive genomic profiling-guided precision therapeutic selection across a major US healthcare system.
Brian Piening(Providence College), Carlo Bifulco(Providence Health & Services), Ryan Meng(Providence Portland Medical Center), Bela Bapat(Illumina (United States)), Lauren Harold(Providence Portland Medical Center), Cliff Wong(Microsoft (United States)), Brock E. Schroeder(Illumina (United States)), Phillip G. Febbo(Veracyte (United States)), Robert Tinn(Microsoft (United States)), Ann Vita(Providence Health & Services), Shu‐Ching Chang(Providence College), Alexa K. Dowdell(Providence Portland Medical Center), Roshanthi Weerasinghe(Providence College), Hoifung Poon(Microsoft (United States))
Cited by 3
Related Papers
Gene expression correlates of clinical prostate cancer behavior
|Cancer Cell|2002|2.5k
The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight
|Science|2019|1.1k
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
|Nature Medicine|2004|956
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803